Weibo Corporation (NASDAQ:WB)
Weibo Corporation (NASDAQ:WB) represented a move of 6.61 percent or $-3.96 per share and closed its previous day trading session at $63.68. 3.61 Million Shares were traded in the last trading session with an Average Volume of 2.4 Million Shares. The stock currently has a Market Capitalization of 13.33 Billion.
Weibo Corporation operates as a social media platform for people to create, distribute and discover Chinese-language content. The Company operates in two segments: Advertising and Marketing Services, and Other Services. The company offers self-expression products; social products; discovery products; notifications; third-party online games. Weibo also develops mobile apps, such as Weibo Headlines; Weibo Weather and WeiDisk. It also provides advertising and marketing solutions, including social display ads and promoted marketing products. Weibo Corporation is headquartered in Beijing, China.
The stock traded between $ 53.11 and $142.12 over 1-Year time period showing its price to sales ratio of 9.04. Weibo Corporation (NASDAQ:WB) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $1.83 and 200-Day Simple Moving Average of $-31.38. Its Price to Free Cash Flow is 0 and Price to Book of 9.06.
Analyst’s recommended the stock as 1.9 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Weibo Corporation (NASDAQ:WB) reported its Actual EPS of $0.75/share. The analysts offering Earnings Estimates for the company were believing that Weibo Corporation could bring EPS of $0.7/share. The difference between Actual EPS and Estimated EPS was 0.05 Percent. Thus showing an Earnings Surprise of 7.1 Percent.
Verastem, Inc. (NASDAQ:VSTM)
In the last trading session, Verastem, Inc. (NASDAQ:VSTM) added its value by 3.03% closing at the price of $5.1. The stock currently has market capitalization of 365.31 Million, with average volume of 3 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Verastem, Inc. (NASDAQ:VSTM) is showing beta of 3.16. This particular value of beta suggests that Verastem, Inc. (NASDAQ:VSTM) has historically moved 316% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Verastem, Inc. (NASDAQ:VSTM) is at $-1.44.
The stock currently has RSI of 44.54. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company’s defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma.
Verastem, Inc. (NASDAQ:VSTM) topped its 52-week high price of $10.35 on 09/04/18 and 52-Week Low Price of $ 2.77 on 04/03/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.65% and monthly volatility of 7.63% respectively.